Projects

Exploring clonal diversity in paediatric B-cell leukaemia to identify new therapeutic weakness

Using demethylating agents to sensitise ependymoma to chemotherapy

The AIM-BRAIN Project: Access to Innovative Molecular diagnostic profiling for paediatric brain tumours

SJ-ELiOT: St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain Tumours

Sensitising glioblastoma to enhance cancer therapy